No Data
No Data
Analysts Have Conflicting Sentiments on These Healthcare Companies: Icon (ICLR), Reviva Pharmaceuticals Holdings (RVPH) and SurModics (SRDX)
Needham Maintains SurModics(SRDX.US) With Hold Rating
Surmodics Reports Q2 2025 Results Amid Acquisition Challenges
SurModics Down Over 8%, On Track for Largest Percent Decrease Since March 2023 -- Data Talk
Surmodics Shares Are Trading Lower. The Company Reported Q2 Financial Results and Issued FY25 Guidance Below Estimates.
Express News | Surmodics Shares Are Trading Lower. The Company Reported Q2 Financial Results and Issued FY25 Guidance Below Estimates